看看瑞典皇家理工学院和乌普萨拉大学的研究员如何使用 Twist 的组合基因突变文库 (CVL) 对先前确定的靶向 VEGFR2 的抗体分子进行工程处理，以对血管形成过程进行基本的生物研究，并潜在地靶向包括癌症和黄斑变性在内的几种疾病的治疗。

Discover how the synthetic advantage can streamline your discovery efforts with Twist Antibody Libraries. Twist Bioscience capitalizes on its massively parallel DNA synthesis platform to generate custom antibody libraries that meet your needs. Complementing this service is the Library of Libraries, a collection of synthetic antibody libraries offered off-the-shelf by Twist Biopharma, a division of Twist Bioscience. Every ready-to-use library offers unique, drug-like antibodies and comes with advanced design support from Twist Biopharma. Compared to those from immunized sources, Twist Antibody Libraries are more diverse, cost-effective, and faster to obtain, making antibody discovery easier than ever before.

Twist 的专有寡核苷酸合成技术提供了一种独特的文库创建方法，采用硅基合成平台生成优质的寡核苷酸池，用于在一片芯片上建立用户确定的、完全定制的基因突变文库。